SCHEMBL20041265

SCHEMBL20041265

NN1CCCC(CNc2ncc(Cl)c(-c3cn(S(=O)(=O)c4ccccc4)c4ccccc34)n2)C1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 11/20 0.43
▸ CCNT1 O60563 1/20 0.42
▸ CDK7 P50613 1/20 0.42
▸ CDK9 P50750 1/20 0.42
▸ CCNH P51946 1/20 0.42
▸ MNAT1 P51948 1/20 0.42
▸ HTR6 P50406 5/20 0.41
▸ DRD2 P14416 4/20 0.41
▸ HTR2A P28223 3/20 0.41
▸ HTR7 P34969 3/20 0.41
▸ HTR1A P08908 1/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CCNC P24863 1/20 0.39
▸ CDK8 P49336 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30886776 0.89 HTR6 (0.43) EGFRCCNT1CDK7CDK9CCNH
SCHEMBL30886760 0.86 CCNT1 (0.55) EGFRCCNT1CDK7CDK9CCNH
SCHEMBL16655454 0.86 CCNT1 (0.55) EGFRCCNT1CDK7CDK9CCNH
SCHEMBL21234246 0.85 LCK (0.42) EGFRCCNT1CDK7CDK9CCNH
SCHEMBL16655163 0.85 HTR6 (0.57) EGFRCCNT1CDK9HTR6
Trifluoroacetic Acid SCHEMBL16654807 0.82 HTR6 (0.41) EGFRCCNT1CDK7CDK9CCNH
SCHEMBL20041226 0.81 CCNT1 (0.61) EGFRCCNT1CDK7CDK9CCNH
SCHEMBL26967533 0.81 CCNT1 (0.61) EGFRCCNT1CDK7CDK9CCNH
SCHEMBL18068876 0.80 CCNK (0.42) EGFRCCNT1CDK7CDK9CCNH
SCHEMBL28545899 0.80 EGFR (0.39) EGFRCCNT1CDK7CDK9CCNH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057955-B1 HETEROAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLFERATIVE DISEASES SYROS PHARMACEUTICALS INC (US) 2018-04-11 — — EP disclosed
Send feedback